| 000 | 01603 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513101408.0 | ||
| 264 | 0 | _c19961114 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm960296c _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRomines, K R | |
| 245 | 0 | 0 |
_aCycloalkylpyranones and cycloalkyldihydropyrones as HIV protease inhibitors: exploring the impact of ring size on structure-activity relationships. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cSep 1996 |
||
| 300 |
_a4125-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aAspartic Acid Endopeptidases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aCyclization |
| 650 | 0 | 4 | _aHIV Protease |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aPyrones _xchemistry |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aSulfonamides _xchemistry |
| 700 | 1 | _aMorris, J K | |
| 700 | 1 | _aHowe, W J | |
| 700 | 1 | _aTomich, P K | |
| 700 | 1 | _aHorng, M M | |
| 700 | 1 | _aChong, K T | |
| 700 | 1 | _aHinshaw, R R | |
| 700 | 1 | _aAnderson, D J | |
| 700 | 1 | _aStrohbach, J W | |
| 700 | 1 | _aTurner, S R | |
| 700 | 1 | _aMizsak, S A | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 39 _gno. 20 _gp. 4125-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm960296c _zAvailable from publisher's website |
| 999 |
_c8825993 _d8825993 |
||